These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 2581531

  • 21. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T, Hara S, Kuriiwa F, Kano S.
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [Abstract] [Full Text] [Related]

  • 22. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L, Asberg M, Bertilsson L, Sjöstrand L.
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [Abstract] [Full Text] [Related]

  • 23. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE, Lawlor BA, Hill JL, Martinez RA, Davis CL, Mellow AM, Rubinow DR, Sunderland T.
    Biol Psychiatry; 1991 Jun 01; 29(11):1110-8. PubMed ID: 1714776
    [Abstract] [Full Text] [Related]

  • 24. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb 01; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 25. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Feb 01; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 26. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM, Tsementzis SA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1979 Oct 01; 42(10):887-91. PubMed ID: 512664
    [Abstract] [Full Text] [Related]

  • 27. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M, Chang WH, Kirk KL, Linnoila M.
    Anal Biochem; 1983 May 01; 131(1):246-53. PubMed ID: 6193730
    [Abstract] [Full Text] [Related]

  • 28. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 01; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 29. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E, Young SN, Lal S, Sourkes TL.
    Brain Res; 1974 Oct 11; 79(1):1-8. PubMed ID: 4279131
    [No Abstract] [Full Text] [Related]

  • 30. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L.
    Neurobiol Aging; 1992 Oct 11; 13(1):107-13. PubMed ID: 1371850
    [Abstract] [Full Text] [Related]

  • 31. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P, Verrier M, Warsh JJ, Price KS.
    J Neurol Neurosurg Psychiatry; 1976 Dec 11; 39(12):1191-200. PubMed ID: 1011029
    [Abstract] [Full Text] [Related]

  • 32. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S, Vermeiren Y, Fransen E, Van Dam D, Aerts T, Gerritsen MJ, Spikman JM, van Laar T, De Deyn PP.
    J Parkinsons Dis; 2018 Dec 11; 8(1):71-84. PubMed ID: 29480224
    [Abstract] [Full Text] [Related]

  • 33. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
    Corona GL, Cucchi ML, Frattini P, Santagostino G, Schinelli S, Romani A, Pola A, Zerbi F, Savoldi F.
    Eur Arch Psychiatry Neurol Sci; 1989 Dec 11; 239(2):79-86. PubMed ID: 2478368
    [Abstract] [Full Text] [Related]

  • 34. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J, Helkala EL, Kutvonen R, Lehtinen M, Riekkinen PJ.
    Psychoneuroendocrinology; 1989 Dec 11; 14(1-2):89-95. PubMed ID: 2471986
    [Abstract] [Full Text] [Related]

  • 35. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 36. Study on monoamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases.
    Ichikawa N.
    Tohoku J Exp Med; 1986 Dec 12; 150(4):435-46. PubMed ID: 2436350
    [Abstract] [Full Text] [Related]

  • 37. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 12; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 38. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ, Walsh FX, Bird ED, Levy HL.
    Pediatrics; 1985 Mar 12; 75(3):580-6. PubMed ID: 2579365
    [Abstract] [Full Text] [Related]

  • 39. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE, Davenport Y, Cowdry RW, Webster MH, Goodwin FK.
    Psychiatry Res; 1980 Mar 12; 2(1):113-9. PubMed ID: 6158064
    [Abstract] [Full Text] [Related]

  • 40. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M, Ninan PT, Scheinin M, Waters RN, Chang WH, Bartko J, van Kammen DP.
    Arch Gen Psychiatry; 1983 Dec 12; 40(12):1290-4. PubMed ID: 6197036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.